Last update 01 Nov 2024

Zhengsu (Shanghai) Biomedical Technology Co., Ltd.

Private Company|
2021|
Shanghai Shi, China

Overview

Tags

Congenital Disorders
Hemic and Lymphatic Diseases
Other Diseases
Transformer Base Editor

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Transformer Base Editor1
Top 5 TargetCount
BCL11A(B-cell lymphoma/leukemia 11A)1

Related

1
Drugs associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
CS-101
Target
BCL11A
Mechanism
BCL11A agonists
Active Org.
CorrectSequence Therapeutics Co., Ltd.CorrectSequence Therapeutics Co., Ltd. [+1]
Originator Org.
CorrectSequence Therapeutics Co., Ltd.CorrectSequence Therapeutics Co., Ltd.
Active Indication
Beta-Thalassemia [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
CTR20241167 / RecruitingPhase 1
一项单臂、开放标签的Ⅰ期临床试验：评估单剂量CS-101注射液治疗重型β-地中海贫血受试者的安全性、耐受性、有效性、药代动力学和药效动力学特征
[Translation] A single-arm, open-label, Phase I clinical trial to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of a single dose of CS-101 injection in subjects with major β-thalassemia
100 Clinical Results associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
Login to view more data
100 Deals associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Zhengsu (Shanghai) Biomedical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CS-101
 ( BCL11A )		Beta-Thalassemia
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free